Company Comparison
Blueprint Medicines vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Blueprint Medicines | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | — |
| Founded | 2011 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $676M | — |
| Valuation | — | — |
What They Build
Blueprint Medicines
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Blueprint Medicines and 10x Genomics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.